TEGSEDI

Peak

inotersen sodium

NDASUBCUTANEOUSSOLUTIONPriority Review
Approved
Oct 2018
Lifecycle
Peak
Competitive Pressure
0/100

Loss of Exclusivity

LOE Date
Apr 29, 2031
62 months away
Patent Expiry
Apr 29, 2031

Patent Records (3)

Patent #ExpiryTypeUse Code
8697860
Apr 29, 2031
Product
—
9061044
Apr 29, 2031
Substance
—
9399774
Apr 29, 2031
U-2430
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history